Briefing Summary: US FDA Blood Products Advisory Committee Posts Materials to Discuss Recombinant Human Coagulation Factor IX GlycoPEGylated; Review Comments on the Donor Deferral Policy for MSM; and Hear About Research in the Laboratory of Emerging Pathogens Report